# Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study

> **NCT00655122** · PHASE4 · TERMINATED · sponsor: **Pfizer** · enrollment: 8 (actual)

## Conditions studied

- Thromboembolism
- Deep Vein Thrombosis
- Dalteparin

## Interventions

- **DRUG:** Dalteparin sodium
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00655122
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** See Detailed Description.
- **Last updated:** 2008-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00655122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00655122, "Prophylaxis In Venous Thromboembolism In Primary Care, A Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00655122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*